济南失神性癫痫发作有哪些症状(日照癫痫病医院怎么样) (今日更新中)

SAN DIEGO (KGTV) - Border Patrol agents and San Diego Police are at the scene of a possible suspicious device in Otay Mesa, officers confirmed Wednesday.Police said they got a call from Border Patrol about 3 p.m. telling them about a possible threat in a vehicle in a tow yard on the 9000 block of Airway Road.The vehicle had been seized during a drug smuggling investigation, police said.San Diego officers sent canine units to the scene and helped establish a perimeter.California Highway Patrol closed one lane on eastbound I-905 exiting onto SR-125. Check traffic here.There was no immediate report of evacuations or information about the type of device.10News is monitoring breaking developments. 709

SAN DIEGO (KGTV) -- California will close state beach parking lots in San Diego County ahead of July Fourth.In a news release Friday, the state listed San Diego among six other counties where parking will also be closed at state beaches.Other state park units will remain open, according to the state, but State Park staff will monitor visitation to ensure compliance with public health orders."Everyone has the responsibility to mitigate the spread of COVID-19, including in the outdoors," the state said. RELATED: Oceanside to close beach parking lots to limit holiday weekend crowdsIn addition, the state says current camping reservations at all state parks will be honored over Fourth of July weekend.The news comes after the City of Oceanside decided Thursday to close beach parking lots over the weekend in an effort to limit holiday gatherings. 859

SAN DIEGO (KGTV) - California Governor Gavin Newsom talked with 10News Thursday in a one-on-one interview.He addressed key topics, including his revised budget plan for 3.5 billion in the upcoming fiscal year. The governor also talked about the death penalty in light of the Poway synagogue shooting, and if cases like it make the Governor rethink his decision to place a moratorium on the death penalty. Newsom also addressed the debate over gun control, his plan to provide more funding for healthcare for undocumented immigrants and an idea to impose a tax on water. 581

SAN DIEGO (KGTV) — Craft beer has a special hold on San Diego, not just locally but internationally as well.Which it's no surprise the region uses more than a week every year to celebrate the contributions brewers have made to San Diego.From Nov. 2 - 11, local craft beer fans can visit participating restaurants, bars, and breweries for special beer releases and events highlighting why San Diego is considered the capital of craft beer.RELATED: Brewery with restaurant and recreation coming to La MesaThe San Diego Brewers Guild kicks things off with Guild Fest, where more than 60 breweries will crowd Embarcadero South to showcase new and favorite brews.The rest of the week is filled with chances for San Diegans to try what's new with beer releases, special food and beer pairings, brewery tours, and special festivals.What better way to enjoy the fruits of the industry's labor in San Diego? San Diego's craft beer scene generated an estimated 1 million in 2015 and employed 4,512 workers, according to the San Diego Regional Economic Development Corporation.For a full list of events, visit San Diego Beer Week's website. 1165

SAN DIEGO (KGTV) — As the world waits for a vaccine against the coronavirus, two San Diego biotechs are teaming up to develop a nasal spray using designer antibodies cloned from COVID-19 survivors.About 70 companies worldwide are working on therapies for COVID-19 using cloned antibodies, according to an estimate by the International AIDS Vaccine Initiative. A few of these treatments, known officially as monoclonal antibody therapies, have advanced to clinical trials.Most require an injection, but San Diego-based Diomics and its partner Active Motif, based in Carlsbad, are developing a once-a-day spray that could be easily self-administered.Early research suggests the coronavirus primarily enters the body through the nose. The spray, called Dioguard, is designed to coat the lining of the nasal cavity with cloned antibodies that are held in place for 24 hours or more using a proprietary polymer material developed by Diomics.Diomics CEO Anthony Zolezzi said he believes the spray “holds the key to allowing many aspects of life to resume until the day comes when there’s an effective vaccine in widespread use.”Diomics is also developing two tests for COVID-19 antibodies using its polymer beads, including a device that looks like a nicotine patch that is designed to monitor for infections for a week or more.RELATED: How a dot on your forearm could be the future sign of COVID immunityActive Motif is providing the cloned antibodies for the nasal spray. With a lab in Shanghai and other relationships in China, the Carlsbad company was able to clone antibodies from 11 Chinese survivors in February, before the World Health Organization declared a pandemic.When the company started the cloning project, they thought the virus would probably disappear in three to six months, said Active Motif CEO Ted DeFrank. “Then people started realizing, no this is going to be with us for a while.”The plasma from the 11 Chinese patients contained thousands of antibodies, and scientists with Active Motif set about selecting the one that was most effective, dubbed 414-1. The company says it can neutralize SARS-CoV-2 virus particles with 98 percent effectiveness.Monoclonal antibodies have some similarities to convalescent plasma, which is a complex cocktail of antibodies and other immune molecules drawn from the blood of recovered patients. One of the key differences is that cloned antibodies can be mass produced in a lab.Cloned antibodies have been used in treatments for more than 30 years, primarily for cancer. One such treatment famously helped former U.S. President Jimmy Carter beat melanoma.But of the more than 100 monoclonal antibody therapies licensed for use, only seven are for communicable diseases, according to IAVI.Historically, the treatments have been expensive and difficult to produce, but Diomics said it’s targeting a price of about a spray for Dioguard, roughly per bottle.“We do not want to have huge profits from a pandemic, that’s just wrong,” Zolezzi said. “We’re going to price this as effectively as we can for the masses. We want to get this out to the masses.”Animal testing is about to begin and the companies said they hope to progress to human trials soon. Their goal is to release the spray in early 2021, when a vaccine may be on the market but not yet widely available.If the spray works, it could be adapted to other viruses to help fight future pandemics, Zolezzi said."That’s our real goal," Zolezzi said. "That we never get caught flat-footed like this time." 3526

来源：资阳报